AQR Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

AQR Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,973	Closed	-$1.55M	–	2238
2019 Q4	$1.55M	Buy	+25,973	New	+$975K	﹤0.01%	1366
2019 Q1	–	Sell	-12,046	Closed	-$257K	–	2270
2018 Q4	$257K	Sell	12,046 -13,637	-53%	-$352K	﹤0.01%	2013
2018 Q3	$1.02M	Buy	25,683 +3,488	+16%	+$130K	﹤0.01%	1700
2018 Q2	$848K	Buy	22,195 +13,719	+162%	+$508K	﹤0.01%	1786
2018 Q1	$255K	Buy	+8,476	New	+$287K	﹤0.01%	2079

AQR Capital Management's BOLD Position: Q1 2020 in Review

AQR Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 25,973 shares — an estimated $1.55M sold.

AQR Capital Management first reported a position in BOLD in Q1 2018 and held it in 5 quarters. The position peaked at $1.55M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

AQR Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
AQR Capital Management sold 25,973 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.55M.
AQR Capital Management first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 5 quarters.
AQR Capital Management's Audentes Therapeutics, Inc position peaked at $1.55M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on AQR Capital Management's 13F filing for Q1 2020, filed 15 May 2020.